Equitec Proprietary Markets »

Revance Therapeutics shares owned by Equitec Proprietary Markets

Quarter-by-quarter ownership of Revance Therapeutics shares owned by Equitec Proprietary Markets from 13F filings

Historical chart of Equitec Proprietary Markets investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Equitec Proprietary Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Equitec Proprietary Markets

Quarter filed Position value Share count Share price at filing
2024-12-31 $912 300 3.04
2024-09-30 $1.6k 300 5.19

More positions owned by Equitec Proprietary Markets

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Netflix Call Option (NFLX)
Paramount Skydance Corp Com Cl B (PSKY)
Kellogg Company (K)
89bio (ETNB)
Electronic Arts (EA)
Siriusxm Holdings Common Stock Call Option (SIRI)
Kayne Anderson Bdc Com Shs (KBDC)
Warner Bros Discovery Com Ser A Put Option (WBD)
Western Midstream Partners L Com Unit Lp Int (WES)
Herc Hldgs Call Option (HRI)
Aris Water Solutions Class A Com (ARIS)
Zimvie (ZIMV)
Tesla Motors Call Option (TSLA)
Scpharmaceuticals (SCPH)

View all positions for Equitec Proprietary Markets